                         SEQUENCE LISTING

<110>  Nesti, Edmund
 
<120>  METHODS AND COMPOSITIONS USEFUL IN MANIPULATING THE STABILITY OF 
       RE1 SILENCING TRANSCRIPTION FACTOR

<130>  1951-1

<150>  US 62/032,438
<151>  2014-08-01

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  101
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

Ile Ser Lys Lys Pro Pro Leu Arg Lys Asp Lys Lys Glu Lys Ser Asn 
1               5                   10                  15      


Met Gln Ser Glu Arg Ala Arg Lys Glu Gln Val Leu Ile Glu Val Gly 
            20                  25                  30          


Leu Val Pro Val Lys Asp Ser Trp Leu Leu Lys Glu Ser Val Ser Thr 
        35                  40                  45              


Glu Asp Leu Ser Pro Pro Ser Pro Pro Leu Pro Lys Glu Asn Leu Arg 
    50                  55                  60                  


Glu Glu Ala Ser Gly Asp Gln Lys Leu Leu Asn Thr Gly Glu Gly Asn 
65                  70                  75                  80  


Lys Glu Ala Pro Leu Gln Lys Val Gly Ala Glu Glu Ala Asp Glu Ser 
                85                  90                  95      


Leu Pro Gly Leu Ala 
            100     


<210>  2
<211>  101
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Ile Ser Lys Lys Pro Pro Leu Arg Lys Asp Lys Lys Glu Lys Ser Asn 
1               5                   10                  15      


Met Gln Ser Glu Arg Ala Arg Lys Glu Gln Val Leu Ile Glu Val Gly 
            20                  25                  30          


Leu Val Pro Val Lys Asp Ser Trp Leu Leu Lys Glu Ser Val Ser Thr 
        35                  40                  45              


Glu Asp Leu Ala Pro Pro Ala Pro Pro Leu Pro Lys Glu Asn Leu Arg 
    50                  55                  60                  


Glu Glu Ala Ser Gly Asp Gln Lys Leu Leu Asn Thr Gly Glu Gly Asn 
65                  70                  75                  80  


Lys Glu Ala Pro Leu Gln Lys Val Gly Ala Glu Glu Ala Asp Glu Ser 
                85                  90                  95      


Leu Pro Gly Leu Ala 
            100     


<210>  3
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  3

Thr Glu Asp Leu Ser Pro Pro Ser Pro Pro Leu Pro Lys 
1               5                   10              


<210>  4
<211>  261
<212>  PRT
<213>  Homo sapiens

<400>  4

Met Asp Ser Ser Ala Val Ile Thr Gln Ile Ser Lys Glu Glu Ala Arg 
1               5                   10                  15      


Gly Pro Leu Arg Gly Lys Gly Asp Gln Lys Ser Ala Ala Ser Gln Lys 
            20                  25                  30          


Pro Arg Ser Arg Gly Ile Leu His Ser Leu Phe Cys Cys Val Cys Arg 
        35                  40                  45              


Asp Asp Gly Glu Ala Leu Pro Ala His Ser Gly Ala Pro Leu Leu Val 
    50                  55                  60                  


Glu Glu Asn Gly Ala Ile Pro Lys Gln Thr Pro Val Gln Tyr Leu Leu 
65                  70                  75                  80  


Pro Glu Ala Lys Ala Gln Asp Ser Asp Lys Ile Cys Val Val Ile Asp 
                85                  90                  95      


Leu Asp Glu Thr Leu Val His Ser Ser Phe Lys Pro Val Asn Asn Ala 
            100                 105                 110         


Asp Phe Ile Ile Pro Val Glu Ile Asp Gly Val Val His Gln Val Tyr 
        115                 120                 125             


Val Leu Lys Arg Pro His Val Asp Glu Phe Leu Gln Arg Met Gly Glu 
    130                 135                 140                 


Leu Phe Glu Cys Val Leu Phe Thr Ala Ser Leu Ala Lys Tyr Ala Asp 
145                 150                 155                 160 


Pro Val Ala Asp Leu Leu Asp Lys Trp Gly Ala Phe Arg Ala Arg Leu 
                165                 170                 175     


Phe Arg Glu Ser Cys Val Phe His Arg Gly Asn Tyr Val Lys Asp Leu 
            180                 185                 190         


Ser Arg Leu Gly Arg Asp Leu Arg Arg Val Leu Ile Leu Asp Asn Ser 
        195                 200                 205             


Pro Ala Ser Tyr Val Phe His Pro Asp Asn Ala Val Pro Val Ala Ser 
    210                 215                 220                 


Trp Phe Asp Asn Met Ser Asp Thr Glu Leu His Asp Leu Leu Pro Phe 
225                 230                 235                 240 


Phe Glu Gln Leu Ser Arg Val Asp Asp Val Tyr Ser Val Leu Arg Gln 
                245                 250                 255     


Pro Arg Pro Gly Ser 
            260     


